Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dowsett

Showing results (241-250 of 304) with videos related to

Pageof 31
Sort By:
Cancer Research|December 4, 2001
HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancerM Dowsett, C Harper-Wynne, I Boeddinghaus, et al.
British Journal of Cancer|January 1, 1982
Effects of endocrine therapy on steroid-receptor content of breast cancerR E Taylor, T J Powles, J Humphreys, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2014
Biomarker changes associated with the development of resistance to aromatase inhibitors (AIs) in estrogen receptor-positive breast cancerM Arnedos, S Drury, M Afentakis, et al.
Breast Cancer Research and Treatment|April 17, 1999
Quantitative changes in cytological molecular markers during primary medical treatment of breast cancer: a pilot studyA Makris, T J Powles, D C Allred, et al.
British Journal of Cancer|March 1, 1990
Phase I/II study of the anti-oestrogen zindoxifene (D16726) in the treatment of advanced breast cancer. A Cancer Research Campaign Phase I/II Clinical Trials Committee studyR C Stein, M Dowsett, D C Cunningham, et al.
Journal of Clinical Pathology|April 3, 2008
HER2 testing in the UK: further update to recommendationsR A Walker, J M S Bartlett, M Dowsett, et al.
Journal of Science and Medicine in Sport|September 11, 2025
A new way of grading severity of ACL rupture on acute MRI to consider potential for non-surgical healing with the Cross Bracing Protocol: ACL Acute Rupture Characteristics for Healing (ACL-ARCH) MRI criteriaS R Filbay, M Dowsett, M van Haeringen, et al.
Cancer Research|August 14, 1999
Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosisS R Johnston, I M Boeddinghaus, S Riddler, et al.
British Journal of Cancer|May 20, 2004
Hormonal impact of the 17alpha-hydroxylase/C(17,20)-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancerA O'Donnell, I Judson, M Dowsett, et al.
British Journal of Cancer|November 1, 1991
Endocrine, pharmacokinetic and clinical studies of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione ('pyridoglutethimide') in postmenopausal breast cancer patientsM Dowsett, F MacNeill, A Mehta, et al.
Pageof 31

Showing results (241-250 of 304) with videos related to

Sort By:
Pageof 31
Cancer Research|December 4, 2001
HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancerM Dowsett, C Harper-Wynne, I Boeddinghaus, et al.
British Journal of Cancer|January 1, 1982
Effects of endocrine therapy on steroid-receptor content of breast cancerR E Taylor, T J Powles, J Humphreys, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2014
Biomarker changes associated with the development of resistance to aromatase inhibitors (AIs) in estrogen receptor-positive breast cancerM Arnedos, S Drury, M Afentakis, et al.
Breast Cancer Research and Treatment|April 17, 1999
Quantitative changes in cytological molecular markers during primary medical treatment of breast cancer: a pilot studyA Makris, T J Powles, D C Allred, et al.
British Journal of Cancer|March 1, 1990
Phase I/II study of the anti-oestrogen zindoxifene (D16726) in the treatment of advanced breast cancer. A Cancer Research Campaign Phase I/II Clinical Trials Committee studyR C Stein, M Dowsett, D C Cunningham, et al.
Journal of Clinical Pathology|April 3, 2008
HER2 testing in the UK: further update to recommendationsR A Walker, J M S Bartlett, M Dowsett, et al.
Journal of Science and Medicine in Sport|September 11, 2025
A new way of grading severity of ACL rupture on acute MRI to consider potential for non-surgical healing with the Cross Bracing Protocol: ACL Acute Rupture Characteristics for Healing (ACL-ARCH) MRI criteriaS R Filbay, M Dowsett, M van Haeringen, et al.
Cancer Research|August 14, 1999
Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosisS R Johnston, I M Boeddinghaus, S Riddler, et al.
British Journal of Cancer|May 20, 2004
Hormonal impact of the 17alpha-hydroxylase/C(17,20)-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancerA O'Donnell, I Judson, M Dowsett, et al.
British Journal of Cancer|November 1, 1991
Endocrine, pharmacokinetic and clinical studies of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione ('pyridoglutethimide') in postmenopausal breast cancer patientsM Dowsett, F MacNeill, A Mehta, et al.
Pageof 31